Search results
Study finds tyrosine kinase Csk promotes germinal center B cell survival and affinity maturation
Medical Xpress· 2 days agoB cells, specialized cells in the immune system that recognize and "remember" foreign factors like bacteria, mature in the germinal center (GC) of immunity-related organs such as the spleen ...
A boost for HIV vaccine research: Studies present comprehensive platform for validating next steps
Medical Xpress· 22 hours agoThe ultimate goal of GT immunization is to coach B cells into producing broadly neutralizing antibodies (bnAbs) capable of binding to conserved sites on HIV Env, which seldom change despite ...
Researchers determine the mutations that protect mice from B-cell cancers
Medical Xpress· 7 days ago"We used a purely genetic method to find a drug target, and that target turns out to be sensational in that B-cell leukemias and lymphomas are strongly ...
Q1 2024 Exscientia PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 hours agoAnd for the first time announcing our plans for our MALT1 inhibitor, XS73565 or 565 as a potential treatment for B-cell lymphomas, including chronic lymphocytic ...
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 6 days agoBristol Myers Squibb cell therapy commercial head and senior vice-president Bryan Campbell stated:...
Cell types and molecules usually associated with autoimmune diseases found to be normal components...
Medical Xpress· 5 days agoThe study is published in Nature. The authors used a combination of spatial transcriptomics and...
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
FOX 59 Indianapolis· 2 days agoHaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the ...
Breaking through the concept barrier to develop broad-spectrum antiviral counter-measures - Nature...
Nature· 2 days agoViruses are small infectious agents that can propagate in the living cells of humans, animals, plants, bacteria and fungi. To date, more than 200 human-infecting viruses have been reported, ...
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration...
Morningstar· 6 days agoBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma 95.7% of patients responded to Breyanzi in the TRANSCEND FL trial Breyanzi provided sustained clinical
ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple...
FOX 23 News Albany· 1 day agoImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to ...
